Mitchell & Pahl Private Wealth, Llc
Source: SEC Form 13F · as of Mar 2026Mitchell & Pahl Private Wealth, Llc holds 14 biotech & pharma companies tracked by BioSniper, totaling $23.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$23.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 18,388 | $4.5M |
| NVSNovartis AG | 22,931 | $3.5M |
| ABBVAbbVie Inc. | 15,289 | $3.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,476 | $2.6M |
| AMGNAMGEN INC | 6,895 | $2.4M |
| AZNASTRAZENECA PLC | 7,142 | $1.4M |
| MRKMerck & Co., Inc. | 10,061 | $1.2M |
| ELANElanco Animal Health Inc | 49,519 | $1.2M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 5,296 | $914K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,009 | $897K |
| NVONovo Nordisk A/S | 17,103 | $629K |
| ZTSZoetis Inc. | 3,339 | $395K |
| IONSIONIS PHARMACEUTICALS INC | 3,261 | $245K |
| ELDNEledon Pharmaceuticals, Inc. | 30,000 | $92K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.